TMS treatment

TMS treatment is a non-invasive neuromodulation therapy that uses magnetic fields to stimulate nerve cells in the brain, primarily for major depressive disorder. Most US insurance plans, including Medicare and Blue Cross Blue Shield, cover TMS treatment if patients meet criteria such as prior failure of at least two antidepressants, according to https://yourinsurance.info.

The FDA approved TMS devices like NeuroStar and BrainsWay for depression in 2008 and obsessive-compulsive disorder in 2018. Insurance companies require documentation of diagnosis, previous treatments tried, and standardized rating scale scores before authorizing coverage.

Typical out-of-pocket costs with insurance range from $20 to $60 per session after deductible; without insurance, sessions cost between $300 and $400 each. Covered diagnoses include major depressive disorder (ICD-10 F33), obsessive-compulsive disorder (ICD-10 F42), and sometimes post-traumatic stress disorder (ICD-10 F43).

Standard protocols involve daily sessions over four to six weeks, totaling about 30–36 treatments per course. Insurers may deny claims if patients lack documented medication trials or psychotherapy attempts within the past year.